Horace Wong1, Corinne Moss1, Steven M Moss2, Vibhuti Shah3, Scott A Halperin4, Shinya Ito5, Priyanjali Mithal1, Angie Qu1, Anna Taddio1,5. 1. a Leslie Dan Faculty of Pharmacy , University of Toronto , Toronto , Ontario , Canada. 2. b Faculty of Medicine , University of Toronto , Toronto , Ontario , Canada. 3. c Department of Pediatrics , Mount Sinai Hospital , Toronto , Ontario , Canada. 4. d Canadian Center for Vaccinology , IWK Health Centre and Dalhousie University , Halifax , Nova Scotia , Canada. 5. e Child Health Evaluative Sciences , The Hospital for Sick Children , Toronto , Ontario , Canada.
Abstract
OBJECTIVES: Recommendations regarding the need to use alcohol prior to vaccine injections are inconsistent and based on low-level evidence. The objective was to assess the effectiveness of alcohol in reducing local skin reactions and infection post-vaccination. METHODS: Randomized controlled trial in a pediatric clinic. A research assistant cleansed the skin with alcohol at (swab group) or adjacent to (control group) the pre-defined injection site(s). Clinicians, parents and children were blinded to group allocation. Parents reported local skin reactions using paper diaries for 15 days post-vaccination (Day 0-14). Telephone interviews were conducted Day 1, 5, and 14. The Brighton Collaboration criteria were used to diagnose cellulitis and infectious abscess Day 5 and afterward. RESULTS:170 children participated (May-November 2017). Baseline characteristics did not differ (p > 0.05) between groups. Children received 1-4 separate injections. There were no differences between swab and control groups in the incidence of any local skin reactions (58% vs. 54%), and specifically, pain (45% vs. 40%), redness (26% vs. 21%), swelling (20% vs. 13%), warmth (19% vs. 27%), and spontaneous drainage of pus (0% in both groups) over the post-vaccination follow-up period. Day 5 data was available for 99% of participants from diaries and telephone surveys; there were no cases of cellulitis or infectious abscess. CONCLUSION: These findings are the first direct evidence for vaccine injections demonstrating that cleansing the skin with alcohol may not be needed. Our study is underpowered; however, to detect a difference in incidence of skin infection, future research is recommended.
RCT Entities:
OBJECTIVES: Recommendations regarding the need to use alcohol prior to vaccine injections are inconsistent and based on low-level evidence. The objective was to assess the effectiveness of alcohol in reducing local skin reactions and infection post-vaccination. METHODS: Randomized controlled trial in a pediatric clinic. A research assistant cleansed the skin with alcohol at (swab group) or adjacent to (control group) the pre-defined injection site(s). Clinicians, parents and children were blinded to group allocation. Parents reported local skin reactions using paper diaries for 15 days post-vaccination (Day 0-14). Telephone interviews were conducted Day 1, 5, and 14. The Brighton Collaboration criteria were used to diagnose cellulitis and infectious abscess Day 5 and afterward. RESULTS: 170 children participated (May-November 2017). Baseline characteristics did not differ (p > 0.05) between groups. Children received 1-4 separate injections. There were no differences between swab and control groups in the incidence of any local skin reactions (58% vs. 54%), and specifically, pain (45% vs. 40%), redness (26% vs. 21%), swelling (20% vs. 13%), warmth (19% vs. 27%), and spontaneous drainage of pus (0% in both groups) over the post-vaccination follow-up period. Day 5 data was available for 99% of participants from diaries and telephone surveys; there were no cases of cellulitis or infectious abscess. CONCLUSION: These findings are the first direct evidence for vaccine injections demonstrating that cleansing the skin with alcohol may not be needed. Our study is underpowered; however, to detect a difference in incidence of skin infection, future research is recommended.
Authors: Scott Halperin; Katrin S Kohl; Jane Gidudu; Leslie Ball; Sandra Jo Hammer; Paul Heath; Renald Hennig; Jerry Labadie; Edward Rothstein; Anne Schuind; Frederick Varricchio; Wikke Walop Journal: Vaccine Date: 2007-05-11 Impact factor: 3.641
Authors: Yvan Hutin; Anja Hauri; Linda Chiarello; Mary Catlin; Barbara Stilwell; Tesfamicael Ghebrehiwet; Julia Garner Journal: Bull World Health Organ Date: 2003-09-03 Impact factor: 9.408
Authors: Nicola P Klein; John Hansen; Chun Chao; Christine Velicer; Michael Emery; Jeff Slezak; Ned Lewis; Kamala Deosaransingh; Lina Sy; Bradley Ackerson; T Craig Cheetham; Kai-Li Liaw; Harpreet Takhar; Steven J Jacobsen Journal: Arch Pediatr Adolesc Med Date: 2012-12